Advancements in Nanotechnology for Targeted Drug Delivery: Applications in Cancer Therapy
American Journal of Biomedical Engineering · 30.06.2022 · 3 (3) · 1-6
DOI: 10.71465/ajbe1525 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Biomedical Engineering, online erschienen am 30.06.2022. Verfasst von Dr. Isabella Morgan. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Nanotechnology has emerged as a promising tool for the targeted delivery of therapeutic agents in cancer therapy. Nanocarriers, such as nanoparticles, liposomes, and dendrimers, offer the ability to encapsulate drugs and deliver them directly to cancer cells, thereby minimizing systemic side effects and improving therapeutic efficacy. This article reviews recent advancements in nanotechnology for targeted drug delivery in cancer therapy, exploring the types of nanocarriers used, mechanisms of drug delivery, and the challenges and future potential of these technologies in clinical oncology.
Zitieren
APA
Morgan, D. I. (2022). Advancements in Nanotechnology for Targeted Drug Delivery: Applications in Cancer Therapy. American Journal of Biomedical Engineering, 3(3), 1-6. https://doi.org/10.71465/ajbe1525
Vancouver
Morgan DI. Advancements in Nanotechnology for Targeted Drug Delivery: Applications in Cancer Therapy. American Journal of Biomedical Engineering. 2022;3(3):1-6. doi:10.71465/ajbe1525
BibTeX
@article{Morgan2022,
author = {Morgan, Dr. Isabella},
title = {Advancements in Nanotechnology for Targeted Drug Delivery: Applications in Cancer Therapy},
journal = {American Journal of Biomedical Engineering},
year = {2022},
volume = {3},
number = {3},
pages = {1--6},
doi = {10.71465/ajbe1525}
}
EUVIMED